# Prospective Evaluation of NfL as a Biomarker in ATTRv

> **NCT05879874** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 40 (estimated)

## Conditions studied

- Amyloidosis, Hereditary

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05879874
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05879874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05879874, "Prospective Evaluation of NfL as a Biomarker in ATTRv". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05879874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*